Proquazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H18N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42VPJ2980S, chemically known as 2(1h)-quinazolinone, 7-methyl-1-(1-methylethyl)-4-phenyl- but generally known as proquazone, which bears US NIH Compound Identifier 31508. European Medicines Agency schedules Proquazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10127MIG. The term PROQUAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules proquazone in its Anatomical Therapeutic Chemical (ATC) Classification. PROQUAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule proquazone under HS 29335995 and SITC 51576. As of Q4 2014, PROQUAZONE remains the US FDA Preferred Term for this commodity. Proquazone bears US NLM identifiers UMLS ID C0072247 and NCI Concept Code C73093. SMILES: O=C1N(C(C)C)C2C(C(N1)C1CCCCC1)CCC(C2)C.